Add-on Acquisition • Life Science

Charles River Laboratories International Acquires Cerebricon Oy

On July 31, 2009, Charles River Laboratories International acquired life science company Cerebricon Oy

Acquisition Context
  • This is Charles River Laboratories International’s 5th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 1st transaction in Finland.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date July 31, 2009
Target Cerebricon Oy
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition

Target Company

Cerebricon Oy

Kuopio, Finland
Cerebricon Oy, provides pharmaceutical discovery services foused on the central nervous system (CNS) diseases category.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

Category Company
Founded 1947
Sector Life Science
Employees18,700
Revenue 4.1B USD (2024)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


Deal Context for Buyer #
Overall 5 of 31
Sector: Life Science 5 of 28
Type: Add-on Acquisition 4 of 26
Country: Finland 1 of 1
Year: 2009 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-03 Piedmont Research Center

Morrisville, North Carolina, United States

Piedmont Research Center LLC is a provider of preclinical discovery services in oncology and other therapeutic areas.

Buy $46M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-01 Systems Pathology Co.

Seattle, Washington, United States

Systems Pathology Co. LLC is a pathology based software development company focused on developing analytical imaging technologies to automate the labor-intensive tissue evaluations process, which is a significant component of standard pre-clinical studies.

Buy -